RPS26P28

Across TCGA pan-cancer cohorts, RPS26P28 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPS26P28’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS26P28 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P28 is over-expressed in tumor, although a few such as PAAD and READ show the opposite, repressed pattern.

COAD, PAAD, and CHOL are the cancer types where RPS26P28 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P28 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+1.274	<.001	9	view →
PAAD	All	All	−0.877	.002	4	view →
CHOL	All	All	+0.395	.005	4	view →
LUAD	All	All	+0.453	.003	3	view →
READ	All	III,IV	−0.260	<.001	2	view →
KIRC	Male	All	+0.156	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPS26P28–COAD

Open the COAD breakdown →